DrugDashboards

Nystatin and Triamcinolone Acetonide

Nystatin and Triamcinolone Acetonide · NYSTATIN 100000 [USP'U]/g; TRIAMCINOLONE ACETONIDE 1 mg/g · Cream · Topical · Lupin Pharmaceuticals, Inc.

NDC 68180-0545-03 · 1 TUBE in 1 CARTON / 60 g in 1 TUBE · ANDA · View full market →

The short version

13 companies supply this market — deep enough that no single failure threatens the supply. The price has held steady around $0.1893 per gram over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 51672-1263-02) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of sale
$0.6838per unit
middle half $0.6106$1.05 · 2,764 plans · Jan 1, 2026
Est. net of rebates
≈ $0.6838
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
50%of plans cover it
tier 4 · prior auth 0% · step therapy 0% · qty limit 30%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 7 quarters since 2024.

NADAC price per unit

$0$0.25$0.5$0.75Mar 2019Sep 2026$0.1893
91 price points · per GMSource: CMS NADAC

Medicaid spend (2025)

$53,553
1,942 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for nystatin and triamcinolone acetonide (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA208205
TE code
AT
Approval date
May 31, 2018
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class III · TerminatedJul 17, 2019
    Lupin Pharmaceuticals Inc.Failed Content Uniformity Specifications: Out-of-specification result observed in uniformity of containers test at 9 month long term stability condition for upright orientation.

Manufacturers of Nystatin and Triamcinolone Acetonide (Cream)

LabelerStrengthFirst seenLast seen
Preferred Pharmaceuticals Inc.NYSTATIN 100000 [USP'U]/g; TRIAMCINOLONE ACETONIDE 1 mg/gJul 15, 2026Sep 3, 2026
Alembic Pharmaceuticals Inc.NYSTATIN 100000 [USP'U]/g; TRIAMCINOLONE ACETONIDE 1 mg/gJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedNYSTATIN 100000 [USP'U]/g; TRIAMCINOLONE ACETONIDE 1 mg/gJul 15, 2026Sep 2, 2026
Crown LaboratoriesNYSTATIN 100000 [USP'U]/g; TRIAMCINOLONE ACETONIDE 1 mg/gJul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., USANYSTATIN 100000 [USP'U]/g; TRIAMCINOLONE ACETONIDE 1 mg/gJul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.NYSTATIN 100000 [USP'U]/g; TRIAMCINOLONE ACETONIDE 1 mg/gJul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedNYSTATIN 100000 [USP'U]/g; TRIAMCINOLONE ACETONIDE 1 mg/gJul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals, Inc.NYSTATIN 100000 [USP'U]/g; TRIAMCINOLONE ACETONIDE 1 mg/gJul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals,Inc.NYSTATIN 100000 [USP'U]/g; TRIAMCINOLONE ACETONIDE 1 mg/gJul 15, 2026Sep 2, 2026
Preferred Pharmaceuticals Inc., USANYSTATIN 100000 [USP'U]/g; TRIAMCINOLONE ACETONIDE 1 mg/gJul 15, 2026Sep 2, 2026
Remedyrepack Inc.NYSTATIN 100000 [USP'U]/g; TRIAMCINOLONE ACETONIDE 1 mg/gJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.NYSTATIN 100000 [USP'U]/g; TRIAMCINOLONE ACETONIDE 1 mg/gJul 15, 2026Sep 2, 2026
Torrent Pharmaceuticals LimitedNYSTATIN 100000 [USP'U]/g; TRIAMCINOLONE ACETONIDE 1 mg/gJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Nystatin and Triamcinolone Acetonide — NDC 68180-0545-03," retrieved September 3, 2026, https://drugdashboards.com/drug/68180054503.

Free to cite with attribution — see how the data is put together.